News Headlines Article

Blue Shield gets whacked again by state regulators, this time over pricing
San Francisco Business Times

State regulators pressured Blue Shield of California to revisit project rate increases for individual, family plan and small group customers in 2016 and 2017, after a review by the state Department of Managed Health Care found that projected drug costs were “higher than estimates by Blue Shield’s peers.” Michelle Rouillard, the DMHC’s director, in an Oct. 5 memo, slammed Blue Shield, saying the public interest requires that the department monitor its medical cost projections “very closely” to see if they prove to be accurate in 2016.